Search research articles
Contact Us
Filters
Showing results (21-30 of 107) with videos related to
Page
of 11
Sort By:
Basic Research in Cardiology
|
January 1, 1991
Does converting enzyme inhibition change the neuronal and extraneuronal uptake of catecholamines?
P Dominiak, A Blöchl
Kidney & Blood Pressure Research
|
October 14, 2000
Vasopeptidase inhibition as a new concept in antihypertensive therapy
A Dendorfer, P Dominiak
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
March 1, 1995
Characterization of bradykinin receptors mediating catecholamine release in PC12 cells
A Dendorfer, P Dominiak
Deutsche Medizinische Wochenschrift (1946)
|
November 1, 2003
[Dosage equivalents of AT1-receptor antagonists available in Germany]
P Dominiak, W Häuser
Medizinische Klinik (Munich, Germany : 1983)
|
January 15, 1991
[Therapy comparison between the combination hydergine/nifedipine and nifedipine alone in patients with isolated systolic hypertension]
P Dominiak, G Weidinger
Fortschritte Der Medizin
|
November 20, 1996
[Therapy of hypertension between claims and reality]
J Scholze, P Dominiak
MMW Fortschritte Der Medizin
|
October 25, 2002
[German Hypertension League on the LIFE Study. New evaluation of AT1 receptor antagonists]
P Dominiak, W Zidek
Deutsche Medizinische Wochenschrift (1946)
|
October 31, 2009
[Analysis of 20,000 calls at the cardiovascular hotline of the German Hypertension Society]
J Leiblein, P Dominiak
Annals of the New York Academy of Sciences
|
July 12, 1995
Imidazoline binding sites on PC12 cells and bovine chromaffin cells
G Steffen, A Dendorfer, P Dominiak
Klinische Wochenschrift
|
January 1, 1984
Changes in peripheral and central catecholaminergic and serotoninergic neurons of rats after acute and subacute administration of nicotine
P Dominiak, F Kees, H Grobecker
Page
of 11
Search research articles
Search
Showing results (21-30 of 107) with videos related to
Sort By:
Page
of 11
Basic Research in Cardiology
|
January 1, 1991
Does converting enzyme inhibition change the neuronal and extraneuronal uptake of catecholamines?
P Dominiak, A Blöchl
Kidney & Blood Pressure Research
|
October 14, 2000
Vasopeptidase inhibition as a new concept in antihypertensive therapy
A Dendorfer, P Dominiak
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
March 1, 1995
Characterization of bradykinin receptors mediating catecholamine release in PC12 cells
A Dendorfer, P Dominiak
Deutsche Medizinische Wochenschrift (1946)
|
November 1, 2003
[Dosage equivalents of AT1-receptor antagonists available in Germany]
P Dominiak, W Häuser
Medizinische Klinik (Munich, Germany : 1983)
|
January 15, 1991
[Therapy comparison between the combination hydergine/nifedipine and nifedipine alone in patients with isolated systolic hypertension]
P Dominiak, G Weidinger
Fortschritte Der Medizin
|
November 20, 1996
[Therapy of hypertension between claims and reality]
J Scholze, P Dominiak
MMW Fortschritte Der Medizin
|
October 25, 2002
[German Hypertension League on the LIFE Study. New evaluation of AT1 receptor antagonists]
P Dominiak, W Zidek
Deutsche Medizinische Wochenschrift (1946)
|
October 31, 2009
[Analysis of 20,000 calls at the cardiovascular hotline of the German Hypertension Society]
J Leiblein, P Dominiak
Annals of the New York Academy of Sciences
|
July 12, 1995
Imidazoline binding sites on PC12 cells and bovine chromaffin cells
G Steffen, A Dendorfer, P Dominiak
Klinische Wochenschrift
|
January 1, 1984
Changes in peripheral and central catecholaminergic and serotoninergic neurons of rats after acute and subacute administration of nicotine
P Dominiak, F Kees, H Grobecker
Page
of 11